Antiangiogenic and antiproliferative activity of suramin analogues

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 2, 1997, Pages 117-124

  Gagliardi, Antonio R T ^a   Kassack, Matthias ^b   Kreimeyer, Annett ^b   Muller, Guido ^b   Nickel, Peter ^b   Collins, Delwood C ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Antiangiogenesis; Antitumorigenesis; Suramin; Suramin analogues

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; BENZENESULFONIC ACID DERIVATIVE; NAPHTHALENETRISULFONIC ACID DERIVATIVE; NAPHTHALENODISULFONIC ACID DERIVATIVE; SURAMIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CHEMICAL STRUCTURE; DOSE RESPONSE; DRUG POTENCY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0031905878     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050717     Document Type: Article

References (25)

1. Bicknell R, Harris AL (1992) Anti-cancer strategies involving the vascular. Vascular targeting and the inhibition of angio-genesis. Semin Cancer Biol 3: 399
2. Bos OJM, Vansterkenburg ELM, Boon JP, Fischer MJ, Wilting J, Janssen LHM (1990) Location and characterization of the suramin binding sites of human serum albumin. Biochem Pharmacol 40: 1595
3. Braddock PS, Hu DE, Fan PD, Stratford IJ, Harris AL, Bicknell R (1994) A structure activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions. Br J Cancer 69: 890
4. Ciomei M, Pastor IW, Mariani M, Sola F, Grandi M, Mongelli N (1994) New sulfonated distamycin a derivatives with bFGF complexing activity. Biochem Pharmacol 47: 295
5. D'Amore PA, Thompson RW (1987) Mechanisms of angiogenesis. Annu Rev Physiol 49: 453
6. Finney DJ (1971) Probit analysis, 3rd edn. Cambridge University Press, London, p 283
7. Firsching A, Nickel P, Mora P, Allolio B (1995) Antiproliferative and angiostatic activity of suramin analogues. Cancer Res 55: 4957
8. Fourneau E, Trefouel J, Vallee J (1924) Recherches de chimioterapie dans la serie du 205 Bayer. Urees des acides- aminobenzoyl amino naphthaleniques. Ann Inst Pasteur 38: 81-114
9. Gagliardi A, Collins DC (1993) Inhibition of angiogenesis by antiestrogens. Cancer Res 53: 533
10. Gagliardi AR, Hadd H, Collins DC (1992) Inhibition of angiogenesis by suramin. Cancer Res 52: 5073
11. Jentsch KD, Hunsmann G, Hartman H, Nickel P (1987) Inhibition of human immunodeficiency virus type I reverse transcriptase by suramin related compounds. J Gen Virol 68: 2183
12. Kassack M, Nickel P (1996) Rapid highly sensitive gradient-narrow bore HPLC determination of suramin and its analogues. J Chromatogr 686: 275
13. Kopp R, Pfeiffer A (1990) Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells. Cancer Res 50: 6490
14. Lees MB, Paxman S (1972) Modification of the Lowry procedure for the analysis of the proteolipid protein. Anal Biochem 47: 184
15. Myers C, Cooper M, Stein CA, La Rocca RV, Walther MM, Weiss GH, Choyke P, Dawson N, Steinberg S, Uhrich MM, Cassidy J, Kohler DR, Trepel J, Linehan DR (1992) Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J Clin Oncol 10: 881
16. Nickel P, Haack H-J, Widjaja H, Ardanuy U, Gurgel C, Duwel D, Loewe H, Raether W (1986) Potentielle Filarizide/Suraminanaloge. Arzneimittel forschung 8: 1153
17. Nickel P, Schott E., Gurgel C, Duwel D, Raether W (1991) Carboxylic acid analogues of suramin. potential filaricides. Ind J Chem 30: 182
18. Olnnder JV, Connolly DT, DeLarco JE (1991) Specific binding of vascular permeability factor to endothelial cells. Biochem Biophys Res Commun 175: 68
19. Olivier S, Formento P, Fischel JL, Etienne MC, Milano G (1990) Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. Eur J Cancer 26: 867
20. Pesenti E, Sola F, Mongelli N, Grandi M, Spreafico F (1992) Suramin prevents neovascularization and tumor growth through blocking of basic fibroblast growth factor activity. Br J Cancer 66: 367
21. Pollack M, Richard M (1990) Suramin blockade of insulin-like growth factor I-stimulated proliferation of human osteosarcoma cells. J Natl Cancer Inst 82: 1349
22. Stein CA, La Rocca RV, Tomas R, McAtee N, Myers CE (1989) Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol 7: 499
23. Takano S, Gately S, Neville ME, Herblin WF, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S (1994) Suramin, an anticancer and angio-suppressive agent inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation and induction of urokinase-type plasminog activator. Cancer Res 64: 2654
24. Wellstein Z, Zugmaier G, Calfano JA, Kern F, Patk S, Lippman ME (1991) Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J Natl Cancer Inst 83: 716
25. Zugmaier G, Lippman ME, Wellstein A (1992) Inhibition of pentosan polysulfate of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. J Natl Cancer Inst 84: 1716